10x Genomics Inc (TXG)
26.00
-0.38
(-1.44%)
USD |
NASDAQ |
May 10, 16:00
26.00
0.00 (0.00%)
After-Hours: 20:00
10x Genomics Cash from Operations (TTM): -26.80M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -26.80M |
December 31, 2023 | -15.20M |
September 30, 2023 | -27.23M |
June 30, 2023 | -11.49M |
March 31, 2023 | -16.93M |
December 31, 2022 | -33.61M |
September 30, 2022 | -41.52M |
June 30, 2022 | -58.18M |
March 31, 2022 | -38.09M |
Date | Value |
---|---|
December 31, 2021 | -21.37M |
September 30, 2021 | -157.35M |
June 30, 2021 | -186.77M |
March 31, 2021 | -219.40M |
December 31, 2020 | -217.90M |
September 30, 2020 | -81.02M |
June 30, 2020 | -10.87M |
March 31, 2020 | 22.73M |
December 31, 2019 | 34.63M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-219.40M
Minimum
Mar 2021
34.63M
Maximum
Dec 2019
-61.47M
Average
-30.42M
Median
Cash from Operations (TTM) Benchmarks
Teladoc Health Inc | 345.78M |
American Shared Hospital Services | 5.718M |
Novo Integrated Sciences Inc | -4.952M |
Astrana Health Inc | 68.23M |
Cryo-Cell International Inc | 6.919M |